BMO analysts said in a note Monday they were “encouraged” that Genmab’s acquisition “could start to spur broader M&A in the sector.” The post Genmab Strikes $8 Billion Deal for Cancer Treatment Maker Merus appeared first on The Daily Upside.| The Daily Upside
A self-administered, under-the-skin injection version of AstraZeneca’s Saphnelo (anifrolumab-fnia) was effective for reducing disease severity in adults with systemic lupus erythematosus (SLE), according to results from an interim analysis of a Phase 3 clinical trial. “Today’s news takes us one step closer in making the clinically meaningful benefits of Saphnelo accessible for more patients with […] The post Trial testing under-the-skin Saphnelo in SLE hits main goal appeared first on...| Lupus News Today – The Web's Daily Resource for Lupus News
Ich habe die KI gefragt, nach aussichtsreichen Unternehmen mit einem KGV von weniger als 13 und einem Börsenwert… Der Beitrag 15 übersehene Aktien mit Potential, unterbewertet! erschien zuerst auf Tim Schäfer Media.| Tim Schäfer Media
Middle and high school science teachers get the opportunity to learn about leading-edge cancer research and learn science skills.| cancer.ufl.edu
AstraZeneca announced May 7th it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a “surplus of available updated vaccines” since the pandemic. A request to withdraw it from European markets had been filed since March The company also proceeded to withdraw the vaccine Vaxzevria’s marketing authorizations within Europe. It submitted a withdrawal […] The post Astrazeneca Withdraws The Covid-19 Vaccine From All Markets Because Of Declining Demand appeared first on He...| Healthcare Weekly
Das Vorgeplänkel Andexanet alfa (Ondexxya) wurde 2019 als Antidot zur Behandlung lebensbedrohlicher Blutungen unter den direkten oralen Antikoagulanzien Apixaban (Eliquis) und Rivaroxaban (Xarelto) (beides Faktor Xa-Antagonisten) zugelassen. Während es mit Idarucizumab (Praxbind) schon seit 2015 ein hochwirksames spezifisches Gegenmittel für Dabigatran (Pradaxa) gab, nach dessen Gabe man auch Notfalleingriffe und auch Thrombolysen durchführen kann, klaffte … Journal Club: ANNEXa-I: Abge...| brainpainblog
